These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18485435)

  • 1. Subchronic exposure to low-doses of the nerve agent VX: physiological, behavioral, histopathological and neurochemical studies.
    Bloch-Shilderman E; Rabinovitz I; Egoz I; Raveh L; Allon N; Grauer E; Gilat E; Weissman BA
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):17-23. PubMed ID: 18485435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining a threshold sub-acute dose leading to minimal physiological alterations following prolonged exposure to the nerve agent VX in rats.
    Bloch-Shilderman E; Rabinovitz I; Egoz I; Yacov G; Allon N; Nili U
    Arch Toxicol; 2018 Feb; 92(2):873-892. PubMed ID: 29127449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits.
    Grauer E; Chapman S; Rabinovitz I; Raveh L; Weissman BA; Kadar T; Allon N
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):265-74. PubMed ID: 18164360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An animal model to study health effects during continuous low-dose exposure to the nerve agent VX.
    Rocksén D; Elfsmark D; Heldestad V; Wallgren K; Cassel G; Göransson Nyberg A
    Toxicology; 2008 Aug; 250(1):32-8. PubMed ID: 18614271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and biochemical evaluation of sub-lethal inhalation exposure to VX in rats.
    Genovese RF; Benton BJ; Lee EH; Shippee SJ; Jakubowski EM
    Toxicology; 2007 Mar; 232(1-2):109-18. PubMed ID: 17234319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute pulmonary toxicity following inhalation exposure to aerosolized VX in anesthetized rats.
    Peng X; Perkins MW; Simons J; Witriol AM; Rodriguez AM; Benjamin BM; Devorak J; Sciuto AM
    Inhal Toxicol; 2014 Jun; 26(7):371-9. PubMed ID: 24766293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive antidotal treatment is crucial in eliminating eye pathology, respiratory toxicity and death following whole-body VX vapor exposure in freely moving rats.
    Bloch-Shilderman E; Yacov G; Cohen L; Egoz I; Gutman H; Gez R; Rabinovitz I; Nili U
    Arch Toxicol; 2019 May; 93(5):1365-1384. PubMed ID: 30729277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
    Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
    Lydon H; Hall C; Matar H; Dalton C; Chipman JK; Graham JS; Chilcott RP
    J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unexpected plasma cholinesterase activity rebound after challenge with a high dose of the nerve agent VX.
    Dorandeu F; Foquin A; Briot R; Delacour C; Denis J; Alonso A; Froment MT; Renault F; Lallement G; Masson P
    Toxicology; 2008 Jun; 248(2-3):151-7. PubMed ID: 18450356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxotremorine-induced hypothermia as a method for evaluating long-term neuronal changes following poisoning by cholinesterase inhibitors in rats.
    Grauer E; Levy A
    Toxicology; 2007 Dec; 242(1-3):1-6. PubMed ID: 17931764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of reversible cholinesterase inhibitors (tacrine, pyridostigmine) and eqbuche against VX poisoning and brain acetylcholinesterase inhibition in rats.
    Bajgar J
    Acta Medica (Hradec Kralove); 2008; 51(4):223-8. PubMed ID: 19453088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality.
    Duysen EG; Li B; Xie W; Schopfer LM; Anderson RS; Broomfield CA; Lockridge O
    J Pharmacol Exp Ther; 2001 Nov; 299(2):528-35. PubMed ID: 11602663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular surface histopathological insult following sarin and VX exposure and potential treatments in the rat model.
    Gore A; Lazar S; Yacov G; Gez R; Rabinowitz I; Nili U; Egoz I; Kadar T
    Toxicol Lett; 2019 Oct; 314():153-163. PubMed ID: 31408696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long-term effects of VX in rat brain cell aggregate culture.
    Sawyer TW; Wang Y; Villanueva M; Song Y; Hennes G
    Toxicol In Vitro; 2022 Feb; 78():105256. PubMed ID: 34653647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination.
    Hamilton MG; Hill I; Conley J; Sawyer TW; Caneva DC; Lundy PM
    Mil Med; 2004 Nov; 169(11):856-62. PubMed ID: 15605929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immobilization of Russian VX skin depots by localized cooling: implications for decontamination and medical countermeasures.
    Mikler J; Tenn C; Worek F; Reiter G; Thiermann H; Garrett M; Bohnert S; Sawyer TW
    Toxicol Lett; 2011 Sep; 206(1):47-53. PubMed ID: 21704135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig.
    Mumford H; Price ME; Wetherell JR
    J Appl Toxicol; 2008 Jul; 28(5):694-702. PubMed ID: 18059069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated exposure to sublethal doses of the organophosphorus compound VX activates BDNF expression in mouse brain.
    Pizarro JM; Chang WE; Bah MJ; Wright LK; Saviolakis GA; Alagappan A; Robison CL; Shah JD; Meyerhoff JL; Cerasoli DM; Midboe EG; Lumley LA
    Toxicol Sci; 2012 Apr; 126(2):497-505. PubMed ID: 22240983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX.
    Nambiar MP; Gordon RK; Rezk PE; Katos AM; Wajda NA; Moran TS; Steele KE; Doctor BP; Sciuto AM
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):142-50. PubMed ID: 17188727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.